The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease-Reference-Cited by-同舟云学术

The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease

Published:1993 Issue: Volume:4 Page:S21-S27
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Goldstone A.H.,McMillan A.K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/4/suppl_1/S21/6678531/4-suppl_1-S21.pdf

Reference45 articles.

1. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma;Appelbaum;Blood,1978

2. Cryopreserved autologous bone marrow transplantation in the treatment of selected paediatric malignancies. A preliminary report;Kaizer;Transplantation Proceedings,1979

3. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation and marrow transplantation;Appelbaum;J Clin Oncol,1987

4. High dose Cyclophosphamide, Carmustine and Etoposide and ABMT for relapsed Hodgkin’s disease;Jagganath;Ann Intern Med,1986

5. High dose chemotherapy and ABMT in refractory Hodgkin’s disease;Philip;Brit J Cancer,1986

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma;Blood;2015-03-12

2. Impact of Conditioning Regimen on Outcome of 2-Year Disease-Free Survivors of Autologous Stem Cell Transplantation for Hodgkin Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2013-08

3. Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation;Leukemia & Lymphoma;2006-01

4. Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma;Bone Marrow Transplantation;2004-11

5. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma;Cancer;2003-05-19